IL-21 modulates CD4+ CD25+ regulatory T-cell homeostasis in experimental autoimmune encephalomyelitis

Scandinavian Journal of Immunology

Volumn 67, Issue 1, 2008, Pages 37-46

  Piao, W H ^a   Jee, Y H ^a,b   Liu, R L ^a   Coons, S W ^a   Kala, M ^a   Collins, M ^c   Young, D A ^c   Campagnolo, D I ^a   Vollmer, T L ^a   Bai, X F ^d   La Cava, A ^e   Shi, F D ^a  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

^b Jeju National University   (South Korea)

^c PFIZER INC   (United States)

^d THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; INTERLEUKIN 12; PROTEOLIPID PROTEIN; TRANSCRIPTION FACTOR FOXP3;

ALLELE; ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HOMEOSTASIS; INFLAMMATORY CELL; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RELAPSE; SEQUENCE HOMOLOGY; SWISS JAMES LAMBERT MOUSE;

AMINO ACID SEQUENCE; ANIMALS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HOMEOSTASIS; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; INTERLEUKINS; MICE; MICE, INBRED C57BL; MICE, MUTANT STRAINS; MOLECULAR SEQUENCE DATA; RECEPTORS, INTERLEUKIN-21; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY;

EID: 36749047463     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2007.02035.x     Document Type: Article

References (27)

1. Parrish-Novak J, Dillon SR, Nelson A et al. Interleukin-21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature 2000 408:57 63.
2. Ozaki K, Kikly K, Michalovich D, Young PR, Leonard WJ. Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc Natl Acad Sci USA 2000 97:11439 44.
3. Leonard WJ, Spolski R. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat Rev Immunol 2005 5:688 98.
4. Sivakumar PV, Foster DC, Clegg CH. Interleukin-21 is a T-helper cytokine that regulates humoral immunity and cell-mediated anti-tumour responses. Immunology 2004 112:177 82.
5. Shang XZ, Ma KY, Radewonuk J et al. IgE isotype switch and IgE production are enhanced in IL-21-deficient but not IFN-gamma-deficient mice in a Th2-biased response. Cell Immunol 2006 241:66 74.
6. Liu R, Van Kaer L, La Cava A et al. Autoreactive T cells mediate NK cell degeneration in autoimmune disease. J Immunol 2006 176:5247 54.
7. Vollmer TL, Liu R, Price M, Rhodes S, La Cava A, Shi F-D. Differential effects of IL-21 during initiation and progression of autoimmunity against neuroantigen. J Immunol 2005 174:2696 701.
8. Pesce J, Kaviratne M, Ramalingam TR et al. The IL-21 receptor augments Th2 effector function and alternative macrophage activation. J Clin Invest 2006 116:2044 55.
9. Jung S, Aliberti J, Graemmel P et al. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 2000 20:4106 14.
10. Sean Riminton D, Körner H, Strickland DH, Lemckert FA, Pollard JD, Sedgwick JD. Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor-deficient, mice. J Exp Med 1998 187:1517 28.
11. Jee Y, Matsumoto Y. Two-step activation of T cells, clonal expansion and subsequent Th1 cytokine production, is essential for the development of clinical autoimmune encephalomyelitis. Eur J Immunol 2001 31:1800 12.
12. Bai XF, Li O, Zhou Q et al. CD24 controls expansion and persistence of autoreactive T cells in the central nervous system during experimental autoimmune encephalomyelitis. J Exp Med 2004 200:447 58.
13. Tuohy VK, Lu Z, Sobel RA, Laursen RA, Lees MB. Identification of an encephalitogenic determinant of myelin proteolipid protein for SJL mice. J Immunol 1989 142:1523 27.
14. Hofstetter HH, Toyka KV, Tary-Lehmann M, Lehmann PV. Kinetics and organ distribution of IL-17-producing CD4 cells in proteolipid protein 139-151 peptide-induced experimental autoimmune encephalomyelitis of SJL mice. J Immunol 2007 178:1372 8.
15. Bettelli E, Carrier Y, Gao W et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006 441:235 8.
16. + regulatory T cells. Nat Immunol 2003 4:330 6.
17. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003 299:1057 61.
18. Ozaki K, Spolski R, Ettinger R et al. Regulation of B cell differentiation and plasma cell generation by IL-21, a novel inducer of Blimp-1 and Bcl-6. J Immunol 2004 173:5361 71.
19. King C, Ilic A, Koelsch K, Sarvetnick N. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 2004 117:265 77.
20. Greer JM, Sobel RA, Sette A, Southwood S, Lees MB, Kuchroo VK. Immunogenic and encephalitogenic epitope clusters of myelin proteolipid protein. J Immunol 1996 156:371 9.
21. Malek TR, Bayer AL. Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol 2004 4:665 74.
22. Apostolou I, Sarukhan A, Klein L, von Boehmer H. Origin of regulatory T cells with known specificity for antigen. Nat Immunol 2002 3:756 63.
23. Young DA, Hegen M, Ma HL et al. Blockade of the interleukin-21/ interleukin-21 receptor pathway ameliorates disease in animal models of rheumatoid arthritis. Arthritis Rheum 2007 56:1152 63.
24. Herber D, Brown TP, Liang S, Young DA, Collins M, Dunussi-Joannopoulos K. IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression. J Immunol 2007 178:3822 30.
25. + T lymphocytes. J Immunol 2007 178:732 9.
26. Zhou L, IvanovII, Spolski R et al. IL-6 programs T (H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007 8:967 74.
27. Korn T, Bettelli E, Gao W et al. IL-21 initiates an alternative pathway to induce proinflammatory T (H)-17 cells. Nature 2007 448:484 7.